ALKS
Alkermes Plc
NASDAQ · Healthcare · Biotechnology · IE
$42.97
+4.25%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 77.49x
- P/E 2028E
- 42.18x
- P/S forward
- 3.81x
Trailing multiples
Trailing twelve months
- P/E TTM
- 106.63x
- PEG TTM
- —
- Price / book
- 3.99x
- Price / sales
- 4.32x
- Price / cash flow
- 28.70x
Enterprise value
- Enterprise value
- $8.1B
- EV / sales
- 4.87x
- EV / EBITDA
- 37.26x
- EV / EBIT
- 69.27x
- Market cap
- $7.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026